ERAS ▼ -8.1% - Erasca, Inc.
$ERAS - Erasca Enters into Clinical Collaboration with Bristol Myers Squibb to Evaluate ERAS-0015 in Clinical Study with Navlimetostat
17-NOV-2026 06:40 PM ET
Share this post
More filings for $ERAS
ERAS - Erasca, Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026ERAS - Erasca, Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026ERAS ▼ -2.0% - Erasca, Inc.Nov 16, 2026ERAS ▼ -6.1% - Erasca, Inc.Nov 12, 2026ERAS ▼ -6.1% - Erasca, Inc.Nov 12, 2026ERAS ▼ -0.1% - Erasca, Inc.Nov 3, 2026
View full $ERAS filing history →💬 Comments
Loading comments…
Leave a comment
